Poland, Dec. 12 -- Poland based AstraZeneca Kft. has secured contract from Dolnoslaskie Centrum Onkologii, Pulmonologii i Hematologii for Medical equipments, pharmaceuticals and personal care products - Delivery of medicinal products from the group: Medicines available under the drug program; Drugs used as part of chemotherapy within the full scope of registered indications and intended uses and in the indication of a specific clinical condition; anticancer and immunomodulatory drugs and non-specific immunoglobulins (according to the ATC classification) divided into 105 tasks. The value of the contract is worth 108869832 PLN.
Published by HT Digital Content Services with permission from Pivotal Sources....